Organon Announces Filing of Form 10-Q for the Quarter Ended March 31, 2021
Organon & Co. (OGN)
Company Research
Source: Business Wire
Company affirms guidance provided during May 3rd Investor Day; will host second quarter earnings call on or about August 12, 2021 JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) (the “company”), today announced that it has filed a Form 10-Q for the quarter ended March 31, 2021. In the filing, the condensed combined financial statements reflect the company’s financial position, results of operations and cash flows as it was operated as part of Merck prior to the spin-off, in conformity with U.S. generally accepted accounting principles ("GAAP"). These condensed combined financial statements do not purport to reflect what the company’s results of operations, comprehensive income, financial position, equity or cash flows would have been had the company operated as a standalone public company during the periods presented.A copy of the Form 10-Q, along with a related Frequently Asked Questions document, and supplemental revenue information, has been posted to the company’s websi
Show less
Read more
Impact Snapshot
Event Time:
OGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGN alerts
High impacting Organon & Co. news events
Weekly update
A roundup of the hottest topics
OGN
News
- Markets Dip but it's Time to Buy These Low-Risk High-Income Stocks [Yahoo! Finance]Yahoo! Finance
- Here's Why You Should Add Cigna (CI) Stock to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]Yahoo! Finance
- Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $16.00 to $18.00. They now have a "neutral" rating on the stock.MarketBeat
- Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National FormularyBusiness Wire
OGN
Earnings
- 2/15/24 - Beat
OGN
Sec Filings
- 3/1/24 - Form 4
- 3/1/24 - Form 4
- 3/1/24 - Form 4
- OGN's page on the SEC website